About Alexander Krupnick
Form D filings for Recourse Biologics in 2024 list Alexander Krupnick as director.
Form D filings also name Alexander Krupnick as a president and director at AskY Therapeutics.
Alexander Krupnick first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Alexander Krupnick in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Alexander Krupnick works with at each company, as listed on that company's latest Form D.
Recourse Biologics, Inc. · Form D, Oct 8, 2024
DW
Daniel Watkins
President and Co-Chief Executive Officer, director
JW
John Westwick
Executive officer and director
AskY Therapeutics, Inc. · Form D, Jun 4, 2024
DW
Dan Watkins
Executive officer and director
JW
John Westwick
Director